Kyverna Therapeutics, Inc Common Stock
Price & Volume
Stats
See more52W Range | $1.78-$13.67 |
Market Cap | $489.3M |
Shares Short | 3M |
Financials
See moreRevenue (12 Mos) | $0 |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | -$137.1M |
Diluted EPS | -$3.73 |
News
See moreYahoo Finance • 2 months ago
Weekly Buzz: CYTK Scores First FDA Approval, INSM Ends Rhinosinusitis Study, XOMA Acquires GBIO
Yahoo Finance • 2 months ago
Biggest stock movers Tuesday: RILY, ORGO, KYTX, RC, LWLG and more
Yahoo Finance • 4 months ago
Kyverna Therapeutics GAAP EPS of -$0.85 misses by $0.04
Yahoo Finance • 4 months ago
Kyverna Therapeutics Provides Business Update and Reports Third Quarter 2025 Financial Results
About
CEO | Mr. Warner Biddle |
Address | 5980 Horton Street, Emeryville, CA, United States, 94608 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 129 |
